Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew B Ward

Showing results (441-450 of 481) with videos related to

Pageof 49
Sort By:
Nature Communications|May 31, 2019
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequenceKwinten Sliepen, Byung Woo Han, Ilja Bontjer, et al.
Nature Communications|November 5, 2023
A combined adjuvant approach primes robust germinal center responses and humoral immunity in non-human primatesIvy Phung, Kristen A Rodrigues, Ester Marina-Zárate, et al.
The Journal of Experimental Medicine|August 30, 2017
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivoMax Medina-Ramírez, Fernando Garces, Amelia Escolano, et al.
Nature|October 30, 2025
Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bitesShirin Ahmadi, Nick J Burlet, Melisa Benard-Valle, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variantsHyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, et al.
Nature Communications|August 4, 2022
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spikeMathieu Claireaux, Tom G Caniels, Marlon de Gast, et al.
Research Square|July 17, 2025
A single residue change only differing by an atomic group can drive imprinting to influenzaJiayi Sun, Gyunghee Jo, Chloe A Troxell, et al.
The Journal of Experimental Medicine|September 5, 2024
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodiesWilliam O Hahn, K Rachael Parks, Mingchao Shen, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
HIV BG505 SOSIP.664 trimer with 3M-052-AF/alum induces human autologous tier-2 neutralizing antibodiesWilliam O Hahn, K Rachael Parks, Mingchao Shen, et al.
Science (New York, N.Y.)|June 20, 2015
HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimersRogier W Sanders, Marit J van Gils, Ronald Derking, et al.
Pageof 49

Showing results (441-450 of 481) with videos related to

Sort By:
Pageof 49
Nature Communications|May 31, 2019
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequenceKwinten Sliepen, Byung Woo Han, Ilja Bontjer, et al.
Nature Communications|November 5, 2023
A combined adjuvant approach primes robust germinal center responses and humoral immunity in non-human primatesIvy Phung, Kristen A Rodrigues, Ester Marina-Zárate, et al.
The Journal of Experimental Medicine|August 30, 2017
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivoMax Medina-Ramírez, Fernando Garces, Amelia Escolano, et al.
Nature|October 30, 2025
Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bitesShirin Ahmadi, Nick J Burlet, Melisa Benard-Valle, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variantsHyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, et al.
Nature Communications|August 4, 2022
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spikeMathieu Claireaux, Tom G Caniels, Marlon de Gast, et al.
Research Square|July 17, 2025
A single residue change only differing by an atomic group can drive imprinting to influenzaJiayi Sun, Gyunghee Jo, Chloe A Troxell, et al.
The Journal of Experimental Medicine|September 5, 2024
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodiesWilliam O Hahn, K Rachael Parks, Mingchao Shen, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
HIV BG505 SOSIP.664 trimer with 3M-052-AF/alum induces human autologous tier-2 neutralizing antibodiesWilliam O Hahn, K Rachael Parks, Mingchao Shen, et al.
Science (New York, N.Y.)|June 20, 2015
HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimersRogier W Sanders, Marit J van Gils, Ronald Derking, et al.
Pageof 49